Validation of prediction models for mismatch repair gene mutations in Koreans

Cancer Research and Treatment

Volumn 48, Issue 2, 2016, Pages 668-675

  Lee, Soo Young ^a   Kim, Duck Woo ^b,c   Shin, Young Kyoung ^c   Ihn, Myong Hoon ^b   Lee, Sung Min ^d   Oh, Heung Kwon ^b   Ku, Ja Lok ^c   Jeong, Seung Yong ^c   Lee, Jae Bong ^b   Ahn, Soyeon ^b   Won, Sungho ^e   Kang, Sung Bum ^b  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Chung General Hospital   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Genetic testing; Hereditary nonpolyposis colorectal neoplasms; Mismatch repair gene; Prediction model

Indexed keywords

MISMATCH REPAIR PROTEIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RISK; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC MODEL; GENETIC RISK; GERMLINE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PREDICTION; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SECOND DEGREE RELATIVE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; AREA UNDER THE CURVE; BIOLOGICAL MODEL; GENETICS; MUTATION; VALIDATION STUDY;

AREA UNDER CURVE; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; GERM-LINE MUTATION; HUMANS; MODELS, GENETIC; MUTATION; SENSITIVITY AND SPECIFICITY;

EID: 84963823297     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2014.288     Document Type: Article

References (25)

1. Rustgi AK. The genetics of hereditary colon cancer. Genes Dev. 2007;21:2525-38
2. Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005;293:1979-85
3. Mensenkamp AR, Vogelaar IP, van Zelst-Stams WA, Goossens M, Ouchene H, Hendriks-Cornelissen SJ, et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatchrepair deficiency in Lynch syndrome-like tumors. Gastroenterology. 2014;146:643-6.e8
4. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010
5. Kastrinos F, Balmana J, Syngal S. Prediction models in Lynch syndrome. Fam Cancer. 2013;12:217-28
6. Monzon JG, Cremin C, Armstrong L, Nuk J, Young S, Horsman DE, et al. Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer. Int J Cancer. 2010;126:930-9
7. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999;116:1453-6
8. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, RuschoffJ, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-8
9. Perez-Carbonell L, Ruiz-Ponte C, Guarinos C, Alenda C, Paya A, Brea A, et al. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Gut. 2012;61:865-72
10. Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. J Med Genet. 2012; 49:151-7
11. Pouchet CJ, Wong N, Chong G, Sheehan MJ, Schneider G, Rosen-Sheidley B, et al. A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers. Ann Oncol. 2009;20:681-8
12. Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med. 2006;354:2751-63
13. Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K, et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA. 2006;296:1479-87
14. Kastrinos F, Steyerberg EW, Mercado R, Balmana J, Holter S, Gallinger S, et al. The PREMM1, 2, 6 model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology. 2011;140:73-81
15. Green RC, Parfrey PS, Woods MO, Younghusband HB. Prediction of Lynch syndrome in consecutive patients with colorectal cancer. J Natl Cancer Inst. 2009;101:331-40
16. Balmana J, Balaguer F, Castellvi-Bel S, Steyerberg EW, Andreu M, Llor X, et al. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J Med Genet. 2008;45:557-63
17. Khan O, Blanco A, Conrad P, Gulden C, Moss TZ, Olopade OI, et al. Performance of Lynch syndrome predictive models in a multi-center US referral population. Am J Gastroenterol. 2011;106:1822-7
18. Tresallet C, Brouquet A, Julie C, Beauchet A, Vallot C, Menegaux F, et al. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome. Int J Cancer. 2012;130:1367-77
19. Kastrinos F, Steyerberg EW, Balmana J, Mercado R, Gallinger S, Haile R, et al. Comparison of the clinical prediction model PREMM(1, 2, 6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut. 2013; 62:272-9
20. Shin YK, Heo SC, Shin JH, Hong SH, Ku JL, Yoo BC, et al. Germline mutations in MLH1, MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families. Hum Mutat. 2004;24:351
21. Oh JR, Kim DW, Lee HS, Lee HE, Lee SM, Jang JH, et al. Microsatellite instability testing in Korean patients with colorectal cancer. Fam Cancer. 2012;11:459-66
22. De Jesus-Monge WE, Gonzalez-Keelan C, Zhao R, Hamilton SR, Rodriguez-Bigas M, Cruz-Correa M. Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer. 2010;9:155-66
23. Park JG, Vasen HF, Park YJ, Park KJ, Peltomaki P, de Leon MP, et al. Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. Int J Colorectal Dis. 2002;17:109-14
24. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128-38
25. Win AK, Macinnis RJ, Dowty JG, Jenkins MA. Criteria and prediction models for mismatch repair gene mutations: a review. J Med Genet. 2013;50:785-93